RCG
MYOK

Rock Creek Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Rock Creek Group’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,394
Closed -$270K – 139
2019
Q2 		$270K Buy
+5,394
New +$263K 0.12% 99

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Rock Creek Group's MYOK Position: Q3 2019 in Review

Rock Creek Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2019, closing a stake of 5,394 shares — an estimated $270K sold.

Rock Creek Group first reported a position in MYOK in Q2 2019 and held it in 1 quarter. The position peaked at $270K in Q2 2019. 157 funds tracked by Wall St. Rank hold MYOK as of Q3 2019.

  • Rock Creek Group reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Rock Creek Group sold 5,394 MyoKardia, Inc. Common Stock shares in Q3 2019, an estimated $270K.
  • Rock Creek Group first reported a position in MyoKardia, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Rock Creek Group's MyoKardia, Inc. Common Stock position peaked at $270K in Q2 2019.
  • 157 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2019.

Based on Rock Creek Group's 13F filing for Q3 2019, filed 13 Nov 2019.